Figure 1
From: Age-specific symptom prevalence in women 35–64 years old: A population-based study

Symptom prevalence. Three months prevalence (%) of 30 symptoms among women 35–64 years of age.
From: Age-specific symptom prevalence in women 35–64 years old: A population-based study
Symptom prevalence. Three months prevalence (%) of 30 symptoms among women 35–64 years of age.